TAVI Registry at the National Research Center for Cardiac Surgery, Astana, Kazakhstan
Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
This study will analyze patients with aortic stenosis who have undergone transcatheter valve implantation and surgical aortic valve replacement. Afterwards, the results of these two procedures will be collected to the database and compared among the Kazakhstani population.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Patients has given written informed Concent for study participation prior to procedure
• Patients with Aortic Valve stenosis
• Patients has severe degenerative or congenital aortic stenosis.
• Patients has symptomatic aortic stenosis as demonstrated by NYHA II or greater
Locations
Other Locations
Kazakhstan
National Research Center for Cardiac Surgery
RECRUITING
Astana
Contact Information
Primary
Abdurashid Mussayev, PhD
abdurashid.mussayev@gmail.com
+77029997667
Backup
Sadyk Khamitov
sadyk.kh@gmail.com
+77055756439
Time Frame
Start Date: 2020-01-10
Estimated Completion Date: 2026-01-10
Participants
Target number of participants: 100
Treatments
Experimental: Patients after transcatheter aortic valve replacement
Patients after transcatheter aortic valve replacement~We will compare TAVI with SAVR data on mortality, intraoperative complications, post-operative complications and adverse cardiovascular events. We will perform Quality of Life analysis before TAVI and one year later, using the Short-Form 36 (SF36) instrument on 70% of our patients.
Active_comparator: Patients after surgical aortic valve replacement
Patients after surgical aortic valve replacement~We will compare TAVI with SAVR data on mortality, intraoperative complications, post-operative complications and adverse cardiovascular events. We will perform Quality of Life analysis before TAVI and one year later, using the Short-Form 36 (SF36) instrument on 70% of our patients.
Related Therapeutic Areas
Sponsors
Leads: National Research Center for Cardiac Surgery, Kazakhstan
Collaborators: Medtronic Cardiovascular